Table 3. Differentially expressed genes in AA tumors are part of pathways with relevance to breast cancer.

Pathway Name	Genes and Transcripts	P-value	P-adj
p73 transcription factor network	ADA, AEN, BUB1, CDK1, HSF1, PML, RAD51	4.75E-05	1.62E-02
Aurora B signaling	AURKB, BUB1, INCENP, KIF20A, KIF23	1.07E-04	1.83E-02
PLK1 signaling events	BUB1, CDC25B, CDK1, INCENP, KIF20A	2.35E-04	2.68E-02
Aurora C signaling	AURKB, INCENP	4.68E-04	3.21E-02
BARD1 signaling events	EWSR1, FANCA, RAD50, RAD51	4.70E-04	3.21E-02

The underlined entry was the only gene not increased in AA samples. Results from the Pathway Interaction Database (http://pid.nci.nih.gov/). Gene names: ADA - adenosine deaminase; AEN - apoptosis enhancing nuclease; AURKB - aurora kinase B; BUB1 - BUB1 mitotic checkpoint serine/threonine kinase; CDC25B - cell division cycle 25B; CDK1 - cyclin-dependent kinase 1; EWSR1 - EWS RNA-binding protein 1; FANCA - Fanconi anemia, complementation group A; HSF1 - heat shock transcription factor 1; INCENP - inner centromere protein antigens 135/155kDa; KIF20A - kinesin family member 20A; KIF23 - kinesin family member 23; PML - promyelocytic leukemia; RAD50 - RAD50 homolog (S. cerevisiae); RAD51 - RAD51 recombinase.